Vecit® 6 mg / 0.4 mg MR Tablets (Solifenacin / Tamsulosin)
Vecit® 6 mg / 0.4 mg MR Tablets (Solifenacin / Tamsulosin)
Vecit® 6 mg / 0.4 mg MR Tablets (Solifenacin / Tamsulosin)
Sitagliptin + Metformin 50 mg / 1000 mg tablets
Vecit® 6 mg / 0.4 mg MR Tablets (Solifenacin / Tamsulosin)
Vecit® 6 mg / 0.4 mg MR Tablets (Solifenacin / Tamsulosin)
Bexarotene 75 mg Soft Capsules
Vecit® 6 mg / 0.4 mg MR Tablets (Solifenacin / Tamsulosin)
Bexarotene 75 mg Soft Capsules
Sitagliptin 25 mg Film-coated Tablets
Sitagliptin 100 mg Film-coated Tablets
Sitagliptin 25 mg Film-coated Tablets
Sitagliptin 50 mg Film-coated Tablets
Sitagliptin 100 mg Film-coated Tablets
Sitagliptin 25 mg Film-coated Tablets
Sitagliptin 100 mg Film-coated Tablets
Sitagliptin 100 mg Film-coated Tablets
Sitagliptin 100 mg Film-coated Tablets
Abiraterone 500 mg film-coated tablets
Icatibant 30 mg Solution for Injection in pre-filled Syringe
Icatibant 30 mg Solution for Injection in pre-filled Syringe
Icatibant 30 mg Solution for Injection in pre-filled Syringe
Icatibant 30 mg Solution for Injection in pre-filled Syringe
Icatibant 30 mg Solution for Injection in pre-filled Syringe
Fesoterodine fumarate 4 mg PR Tablets
Fesoterodine fumarate 4 mg PR Tablets
Fesoterodine fumarate 4 mg PR Tablets
Fesoterodine fumarate 8 mg PR Tablets
Fesoterodine fumarate 4 mg PR Tablets
Fesoterodine fumarate 4 mg PR Tablets
Generic product portfolio
Celix Pharma is developing a pipeline of generic products across a range of dosage forms (OSD, Injectable, Opthalmics, Liquids) and therapeutic categories, catering to both primary and secondary care channels. Each product has a story and aims to address an unmet need within the healthcare system. The approach to product selection is grounded in the knowledge of the market and the supply chain behind each product. The portfolio has a good mix of complex specialty generics, products with limited suppliers and products which pose high technical barriers from either a development or manufacturing perspective.